Overview
- Peer-reviewed research in Science Immunology pinpoints monocyte-derived IL-10 as an active mechanism that resolves pain and is more robust in males.
- In mice, deleting Il10 in monocytes or the Il10 receptor in sensory neurons impeded recovery, demonstrating causality in the IL-10 pathway.
- A human cohort of about 245 trauma patients showed men’s pain subsided faster and correlated with higher circulating IL-10 and more IL-10–producing monocytes.
- Androgen signaling increased IL-10 production: blocking male hormones removed the male advantage, while testosterone given to female mice boosted IL-10+ monocytes and accelerated recovery.
- Enhancing IL-10+ monocytes with resolvin D1 eliminated sex differences in mice, suggesting non-opioid targets, though experts caution human therapies remain unproven and may not explain all chronic pain conditions.